Facilitated By

San Antonio Medical Foundation

A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF ALXN1210 IN CHILDREN AND ADOLESCENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Assanasen, Chatchawin
Funded by
ALEXION PHARMACEUTICALS
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Other